Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Santarus Inc

SNTS:US

Acquired

Company Profile for Santarus Inc (SNTS)

Santarus, Inc. focuses on acquiring, developing, and commercializing proprietary products. The Company offers budesonide, bromocriptine mesylate, fenofibrate, omeprazole, and metformin hydrochloride extended release tablets. Santarus operates in the State of California.

Contact Information

Santarus Inc

12230 El Camino Real
Suite 300
San Diego, CA 92130
United States
Phone: 1-858-314-5700
Fax: 1-858-314-5701

Key Executives for Santarus Inc (SNTS)

Timothy J Creech "Tim"PresidentTeri L ChuppeVP/Controller
Jonathan M HeeVP:Commercial AffairsMartha L HoughVP:Finance
Thomas J JoyceVP:Mktg & Natl AccountsBlake A BolandVP:Sales
William C Bertrand JrSecretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil